U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them.
Independent monitors had paused enrollment in the study two weeks ago because of a possible safety issue. But on ...
from www.washingtontimes.com stories: Health https://ift.tt/2IZc4BJ